Skip to main content

Investors
- - - Investors
      
      We are COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
  - - News & events
    - Stock information
  - - Corporate governance
    - Investor resources
  - - COMP360 psilocybin therapy in TRD
      
      We have completed the largest randomised, controlled, double-blind psilocybin therapy study ever done.
      
      Read more about COMP360 psilocybin therapy in TRD
LinkedIn
Youtube
Why we exist
Our values
Our approach
Careers
60 seconds with ...
Our perspectives
Our stories
Podcast
COMPASS news archive

High Contrast
Greyscale
Negative Contrast
Readable
Reset

Search for news

News & views

Sorry, nothing to display.

[seopress_breadcrumbs]

This website is powered by renewable energy

Useful links

LinkedIn
Youtube

Sign up to receive the latest COMPASS news.

Subscribe

myPathfinder privacy

The press releases and articles contained in this section are provided for historical purposes only. The information contained in each press release and article is accurate only as of the date each press release and article was originally issued. COMPASS disavows any obligation to update the information contained in such press releases and articles after the date of their issuance.

You are now leaving COMPASS Pathways’ website.

COMPASS does not control and is not responsible for the content on the website you are about to visit. COMPASS is providing this link as a convenience, and this link does not imply COMPASS endorsement of any material on the website you are about to visit. Do you wish to continue?